Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
This young baker tore up the instructions for starting a business (but kept all the best recipes)
Overland Park cookie shop gets a new baker behind the counter, adding a frosted twist to familiar favorites She learned to bake as a child by her grandmother’s side. So by middle school, Maddie Callicott was so proficient she not only held popular bake sales, she printed up business cards for her “You Take the…
Brick by brick: How used LEGOs are making innovation more tangible for KC kids in need
Solopreneur Rhonda Jolyean Hale believes that all children deserve access to play — no matter their circumstances. As the Kansas City ambassador for the Pass the Bricks initiative, she’s working to build that reality by giving new life to donated LEGO bricks. “We take gently used LEGO bricks — not the stuff the dog chews…
Novel Capital teams with Crux KC to offer growth-focused marketing to early-stage tech companies
An exclusive partnership between two Kansas City-based innovators is expected to help remove a traditional financial hurdle to business growth, said Ethan Whitehill, president and chief strategy officer for the KC Chamber-lauded marketing firm Crux KC. The collaboration between Crux and Overland Park-headquartered capital provider Novel Capital is expected to offer B2B SaaS and tech…
Neighborhood smart cans help Kansas Citians save the planet from their kitchens
Newly introduced composting technology is already turning new ground in Kansas City, Kristan Chamberlain said, with more solar-powered compost cans arriving later this spring across the metro’s urban landscape. Her social venture, KC Can Compost, installed three of the devices in October — free to use for KCMO residents wanting to deposit their soil-making food…